Search

everythinglearnresearchcommunity

for

Search:↓

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Higher aldosterone levels link to hair loss and high blood pressure.

Nanotechnology could make hair loss treatments more effective and reduce side effects, but more research is needed before it's available.

Testosterone improves mood and thinking skills; finasteride has no effect.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Dutasteride mesotherapy helps treat male hair loss but may harm sperm and sexual function.

Nanoparticles show potential for controlled release of hair loss drugs, improving treatment effectiveness.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Hair loss in men is common, treatable, but not curable.

Hair loss needs more research for better treatments.

Use minoxidil for hair loss treatment; assess results after 6 months.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.